H-Type Hypertension and C Reactive Protein in Recurrence of Ischemic Stroke

Qing Zhang1, De-Xing Qiu2, Rong-Li Fu3

  • 1Institute of Public Health, School of Nursing, Henan University, Kaifeng 475004, China. zq71200@163.com.

Insights

Recurrent ischemic stroke (RIS) is linked to H-type hypertension and elevated C-reactive protein (CRP). Managing these factors may help reduce the risk of stroke recurrence.

Area of Science:

  • Neurology
  • Cardiology
  • Clinical Biochemistry

Background:

  • Hypertension with high homocysteine (H-type hypertension) and elevated C-reactive protein (CRP) are known risk factors for ischemic stroke.
  • The association between H-type hypertension, CRP levels, and recurrent ischemic stroke (RIS) remains unclear.

Purpose of the Study:

  • To investigate the correlation between H-type hypertension and CRP levels with the incidence of recurrent ischemic stroke (RIS).

Main Methods:

  • A cohort of 987 consecutive patients with acute ischemic stroke was analyzed.
  • Demographic, clinical, and biochemical parameters, including CRP and homocysteine (Hcy) levels, were assessed.
  • Multivariate analysis was used to identify independent risk factors for RIS.

Main Results:

  • Among 987 patients, 234 experienced RIS.
  • Elevated CRP levels were found in 38% of RIS patients, and 91.5% had H-type hypertension.
  • Independent risk factors for RIS included older age, male sex, diabetes, H-type hypertension, and elevated CRP levels.

Conclusions:

  • H-type hypertension and elevated CRP levels are significantly associated with an increased risk of recurrent ischemic stroke.
  • Controlling H-type hypertension and CRP levels may be a viable strategy to reduce the incidence of RIS.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
730
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
958
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K